Highlights

  • FY26 premium Revenue increased 4.6% to A$8.59 billion, while Health Insurance operating profit rose 3.8% to A$769.8 million.
  • Group net profit after tax increased to A$638.7 million, although Underlying Profit growth was more modest at 2.9%.
  • Medibank Health revenue rose 30.8% to A$634.8 million and segment profit increased 31.3% to A$100.7 million.
  • Resident policyholders increased by 22,100, with ahm recording faster growth than the Medibank brand.
  • FY27 guidance points to broadly stable resident insurance margins and further growth in Medibank Health.

Medibank Private Ltd (ASX:MPL) is an Australian private health insurer operating the Medibank and ahm brands, while also providing health services through its Medibank Health division. The FY26 result shows steady core insurance operations alongside faster growth in the smaller health-services arm, increasing the importance of execution beyond traditional premium and claims management.

Insurance Earnings Grow as Claims Keep Pace With Premiums

For the year ended 30 June 2026, health insurance premium revenue rose 4.6% to A$8,585.1 million. Segment operating profit increased 3.8% to A$769.8 million, while the gross Margin held at 17.0% and the expense ratio remained 8.0%. Gross claims increased 4.7% to A$7,140.0 million, meaning claims growth broadly matched the increase in premium income. This kept margin expansion limited and places emphasis on pricing, claims management and costs.

Reported Profit Rises Faster Than Underlying Earnings

Group net profit after tax increased 27.5% to A$638.7 million, but underlying profit rose only 2.9% to A$636.8 million. The underlying measure better reflects the recurring operating trend. Underlying Earnings Per Share were 23.1 cents. Net Investment income declined 13.9% to A$178.9 million on an investment portfolio of A$3.4 billion, partially offsetting improvement from the operating businesses.

Medibank Health Becomes a Larger Earnings Contributor

Medibank Health produced revenue of A$634.8 million, up 30.8%, and segment profit of A$100.7 million, up 31.3%. The Better Medical Acquisition contributed to the expansion, with previously unallocated Capital used to fund the transaction. For FY27, Medibank expects approximately 25% segment profit growth, including a full-year contribution from Better Medical. The division remains smaller than health insurance, but its faster growth makes integration, service Demand and acquisition discipline more relevant to group earnings.

Membership, Capital and Dividends

Resident policyholders increased by 22,100, or 1.1%. The Medibank Brand grew 0.6%, while ahm increased 2.4%. Non-resident policyholders declined 2.3% as student policies ran off. Medibank declared total fully franked FY26 dividends of 19.2 cents per share, representing 83.0% of underlying profit and remaining within its stated payout range. Prudential capital coverage improved to 1.9 times, although unallocated capital fell to A$182.9 million after funding Better Medical.

Cyber Costs and FY27 Watch Points

Cyber-related costs fell to A$34.9 million in FY26 from A$39.7 million, and management expects them to decline below A$20 million in FY27. Lower spending does not establish resolution of the associated regulatory or legal matters. For FY27, Medibank expects the resident gross margin to remain broadly consistent with FY26 and anticipates continued growth in Medibank Health. Claims inflation, premium approvals, member competition, investment returns and execution within the expanding health-services Business remain the main operating variables to monitor.

Key Insights

Medibank entered FY27 with a stable core insurance margin, modest member growth and a faster-growing health-services division. The central operating question is whether Medibank Health can continue expanding without weakening capital flexibility or increasing integration risk. At the same time, the insurance business remains sensitive to claims costs and premium settings, while investment income and unresolved cyber-related matters add further variability to reported earnings.